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This report describes two patients who had developed asthma after working as automobile painters with 
isocyanate-based aerosol paint for two years or over. In both patients asthma was confirmed using the 
standard diagnostic procedure. One of the subjects was atopic. One was ex-smoker and the other had never 
smoked. Neither had a family history of asthma. The symptoms occurred after workplace exposure lasting 
two years in one patient and three in the other. As both reported work-relatedness of the symptoms, they 
underwent serial peak expiratory flow rate (PEFR) measurement and bronchoprovocation testing. Significant 
work-related changes in PEFR diurnal variations and in non-specific bronchial hyperresponsiveness (NSBH) 
were observed in one patient, suggesting allergic occupational asthma (OA), while the other patient was 
diagnosed work-exacerbated asthma (WEA). Our data confirm that spray painting is an occupation with 
increased risk of respiratory impairment and asthma.
KEY WORDS: bronchial provocation tests, isocyanates, occupational asthma, peak expiratory flow 
rate, work-exacerbated asthma
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Asthma rates are rising throughout the world, and 
environmental and occupational factors are being 
scrutinised in search of explanations. Workplace 
exposure can trigger or induce asthma and cause 
different types of work-related asthma (WRA) (1). 
WRA is a broad term encompassing occupational 
asthma (OA), that may be allergic and non-allergic or 
irritant-induced, and work-exacerbated asthma (WEA) 
(1, 2). Over the last few decades WRA has become 
the most common work-related respiratory disorder 
in the industrialised countries, contributing to 10 % to 
29 % of all adult asthma cases (3-5). According to the 
results of a polycentric study carried out in 2003, the 
prevalence of asthma in the age group 20 to 44 years 
in Macedonia was 5.4 % and work-relatedness of the 
disease was reported in 24.7 % asthma patients (6).
There is evidence of WRA among spray painters 
using isocyanate-based aerosol paint. According 
to the European Community Respiratory Health 
Survey (ECRHS) classification, spray painting 
is considered an occupation with a high risk of 
respiratory impairment and asthma (occupational 
set “spray painters”) (7, 8). It is well-established 
that workplace exposure to polyisocyanates, low-
molecular-weight compounds used in the manufacture 
of polyurethane paints, varnishes, and plastics, may 
lead to respiratory impairment. Polyurethane paints 
containing isocyanate hardeners were introduced in 
the automobile refinishing market in the late 1960s 
to provide resistance to weather and sunlight, and 
came into wide use in the 1980s (9). Despite the 
acknowledged risk, widespread use of isocyanates in 
the paint systems used in the automotive repair and 
refinishing industry still entails exposure. This is an 
industry of primarily small, often family-owned repair 
shops with a few employed workers. The workers are 
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usually specialised in specific operations  removal 
of damage, frame straightening, and welding are 
performed by mechanics while masking/taping, 
spraying basecoat and clearcoat, gun cleaning, 
untaping, compounding, washing, and detailing 
are performed by painters. Many studies indicate 
significant exposure to isocyanates in this industry 
(10-12).
Our study describes two automobile painters 




This study included two subjects who were 
examined at the Institute of Occupational Health, 
Skopje (IOH) in 2006 and 2007. Asthma diagnosis was 
confirmed using the standard diagnostic procedure, 
while OA diagnosis was confirmed by serial monitoring 
of peak expiratory flow rate (PEFR) and by serial 
bronchoprovocation testing.
Clinical history
The presence of respiratory symptoms suggestive 
of asthma (wheezing, shortness of breath, chest 
tightness, cough, and asthma attacks) was documented 
using the ECRHS questionnaire (13). The subjects 
were asked about the onset (before or after entering 
the actual workplace; sudden or progressive) and 
work-relatedness of the symptoms (worsening of the 
symptoms during or after work shifts and improving 
during weekends and vacations).
We took and evaluated a detailed occupational 
history, including current and previous occupations. 
The subjects were asked about the characteristics of 
the working process, appliances and materials used, 
duration of the working shifts, and use of protective 
equipment. We also evaluated smoking history, family 
history of asthma and allergies (taking into account 
the first-degree relatives), accompanying disease, and 
use of medications.
Skin prick tests
Skin prick tests (SPT) to the common inhalant 
allergens were performed on the volar part of the 
forearm using allergen extracts (Torlak, Serbia) of 
birch (5000 PNU), lime (5000 PNU), mixed grass 
(Agrostis alba, Alopecurus pralensis, Dactylis 
glomerata, Festuca pranesis, Phleum pratense, Poa 
pratensis, Secale cereale, Triticum aestivum, and 
Zea mais; 5000 PNU), mugwort (5000 PNU), plantain 
(5000 PNU), mixed fungi (Alternaria alternata, 
Aspergilus fumigatus, Mucor, Penicillium notatum, 
Cladosporium herbarum, Candida albicans, and 
Trychophyton; 4000 PNU), Dermatophagoides 
pteronyssinus (4000 PNU), dog hair (4000 PNU), 
cat fur (4000 PNU), and mixed feathers (chicken and 
duck feathers; 4000 PNU). All tests included positive 
(1 mg mL-1 histamine) and negative (0.9 % saline) 
controls. Skin prick tests were considered positive 
if the mean wheal diameter 20 min after allergen 
application was at least 3 mm larger than negative 
control (14).
Spirometry
Spirometry, including measurements of forced 
vital capacity (FVC), forced expiratory volume in one 
second (FEV1), FEV1/FVC ratio, maximal expiratory 
flow at 50 %, 25 %, and 25 %-75 % of FVC (MEF50,
MEF25, and MEF25-75, respectively), was performed 
recording the best of three measurements by 
spirometer Ganshorn SanoScope LF8 (Ganshorn 
Medizin Electronic GmbH, Germany). The results were 
expressed as percentages of the predicted values, 
according to the European Community for Coal and 
Steel (ECCS) standards (15).
Histamine challenge
The histamine challenge tests were performed 
according to the European Respiratory Society (ERS) 
recommendations (16). Concentrations of 0.5 mg 
mL-1, 1 mg mL-1, 2 mg mL-1, 4 mg mL-1, and 
8 mg mL-1 histamine (Torlak, Serbia) were prepared 
by dilution with buffered saline. The doses of aerosol 
generated by Pari LC nebulizer (Pari GmbH, Germany) 
were inhaled through a mouthpiece. The subjects 
inhaled increasing concentrations of histamine using 
a tidal breathing method until FEV1 fell by more than 
20 % of its baseline value (provocative concentration 
20 - PC20) or the highest concentration was reached. 
The test was considered positive if PC20 was equal or 
less than 4 mg mL-1.
Asthma diagnosis
According to the American Thoracic Society 
(ATS) and Global Initiative for Asthma (GINA) 
recommendations (17, 18), current asthma is defined 
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as a presence of asthma-suggestive symptoms and 
positive histamine challenge.
Serial PEFR measurement
Serial PEFR measurements were performed using 
a PEFR-meter asmaPLAN+ (Vitalograph Ltd., Ireland) 
according to the ERS recommendations. To provide 
an adequate representation of days at work and days 
away from work, a positive record should include two 
weeks at work and two weekends away from work, and 
a negative record should include two weeks away from 
work, while PEFR measurements should be carried 
out at least 4 times a day (19).
Before taking PEFR self-measurements the 
subjects received instructions how to use the meter. 
They were instructed to record the highest of three 
readings only if the two best readings were within 
20 L min-1 of each other. Measurements were taken 
four times a day from the morning till bedtime at 
similar times at and away from work. Readings were 
interpreted by analysing their diurnal variation. The 
test was considered positive when PEFR varied 20 % or 
more (calculated as maximum PEFR minus minimum 
PEFR divided by maximum PEFR) between working 
days, and days off work.
Serial nonspecific bronchoprovocation testing
Both subjects were also given serial histamine 
challenge on a work day and then nonspecific BHR 
was reassessed after at least two weeks away from 
work. The test was considered positive when BHR 
improved by at least two doubling concentrations of 
histamine while away from work (20).
Diagnosis of the WRA type
According to current ERS recommendations (1, 
19, 20), allergic OA is defined as a diagnosed asthma 
that occurred after entering the current workplace with 
work-relatedness of the symptoms confirmed by serial 
PEFR monitoring or serial bronchoprovocation testing. 
Irritant-induced asthma (reactive airways dysfunctional 
syndrome - RADS) is defined as asthma with a sudden 
onset after an acute, high-level irritant exposure in 
a subject with documented absence of preceding 
respiratory complaints (1, 19). WEA is defined as a pre-
existing or a new-onset asthma whose symptoms have 
worsened due to workplace environmental exposure, 
and is diagnosed by exclusion of OA (1).
Semi-quantitative risk assessment
We performed the semi-quantitative risk 
assessment at the subject’s workplace according 
to the recommendations of “A Code of Practice for 
Risk Assessment, Advanced Techniques: June 2001” 
(21). The risk of adverse respiratory effects, rated as 
high, medium and low, was calculated taking account 
known and reasonably foreseeable hazards, effects 
that they could have, and probability of the event.
CASE REPORTS
Baseline clinical and functional data for the study 
patients are given in Table 1.
Subject 1.
Subject 1 was a 42-year old man who had never 
smoked,  and had worked for four years in a car 
repair shop with 16 other workers. Before that he 
had worked as a driver for 17 years. At the current 
workplace he performed painting operations using 
isocyanate-based aerosol paints and his work shift 
was eight hours a day. These painting operations were 
performed in a large enclosed unit with an exhaust 
system consisting of a fan drawing air through filters 
into a plenum at the back of the unit and releasing it 




















4 2 91 77
2 52 + Ex- smoker 5 2 87 75
FEV1: forced expiratory volume in one second; FVC: forced vital capacity; % pred: percentage of the predicted value.
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outdoors. He reported painting about 20 to 25 cars 
per month, nearly every working day. His protective 
equipment consisted of protective clothing, gloves, 
and a simple air-filtering mask covering the nostrils. 
According to our semi-quantitative risk assessment, 
his workplace involved a medium risk of respiratory 
impairment.
At the first visit to the IOH Subject 1 reported 
progressive cough, shortness of breath, wheezing, 
and chest tightness over the previous two years. 
His symptoms typically occurred after the work 
shift, and on workdays he would wake at night with 
chest symptoms. The symptoms would improve 
with the application oral theophylline and/or inhaled 
salbutamol. During weekends and holidays the 
symptoms would completely clear, and he could 
stop taking medications. On his return to work the 
symptoms would recur within one or two days. He did 
not report any previous disease, and had no family 
history of asthma and allergies.
At his first visit, he was symptom-free, having 
been away from work for two weeks. He showed 
normal spirometric parameters, negative SPT to 
common inhalant allergens, and positive histamine 
challenge (PC20 = 4 mg mL-1) which confirmed 
asthma diagnosis. As the subject reported work-
relatedness of the symptoms and as there is a risk 
of allergic OA in spray painters, he underwent serial 
PEFR measurements and serial bronchoprovocation 
testing.
PEFR measurement showed significant changes 
between mean diurnal variations on days away from 
work and days at work (Figure 1).
Serial bronchoprovocation testing also showed 
significant differences in NSBH between days away 
from work and days at work; PC20 on days away 
from work was three double concentrations of 
histamine lower than on days at work (4 mg mL-1 vs.
0.5 mg mL-1).
Significant work-related changes in mean PEFR 
diurnal variations and NSBH suggested allergic OA. 
Asthma management included moving the subject 
away from exposure and pharmacological anti-asthma 
treatment.
Subject 2 
Subject 2 was a 52-year-old man who had worked 
for four years in a car repair shop with seven other 
workers, and before that he had worked as a shop 
assistant in spare parts and accessories store for 22 
years. Similar to Subject 1, at the current workplace he 
performed painting operations using isocyanate-based 
aerosol paints, and his work shift also lasted eight 
hours a day. The painting operations were performed 
in a “home-made” booth without a ventilation system 
that had just been installed. He reported painting 12 
to 15 cars per month, usually 4 to 5 times a week. 
Throughout the workshift he wore a working outfit, 
gloves, and simple mask for spraying. According to 
our semi-quantitative risk assessment his workplace 
involved  a high risk of adverse respiratory effects.
He had a history of mild arterial hypertension over 
the last eight years and was treated with lysinopril. He 
also reported recurrent bronchitis in the childhood 
with productive cough and shortness of breath, but he 
Figure 1 Plot of maximum, mean, and minimum peak expiratory flow rate (PEFR) against time showing significant changes in mean PEFR diurnal
variations on days away from work and days at work (8.1 % vs. 21.4 %, P = 0.000; independent samples t-test). Days away from work
1-15, days at work 16-30.
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was not evaluated for asthma at the time. However, he 
had had no respiratory complaint in the last 30 years. 
His mother suffered from seasonal allergic rhinitis, but 
he had no family history of asthma. He nad not been 
smoking for the last eight years, and before that he 
had smoked 20 cigarettes a day for 20 years. 
He had been symptom-free until three years 
before his first visit to IOH, at which time he had 
rhinorrhoea, cough, shortness of breath, wheezing, 
and exercise intolerance. These symptoms occurred 
progressively and were more pronounced during and 
after work, occasionally causing him to wake at night. 
His symptoms improved with inhaled salbutamol, 
and decreased after two weeks away from work. They 
returned after two days at work and were controlled by 
inhaled salbutamol two to three times daily.
At the first visit, the subject reported only a 
mild cough, having been away from work for two 
weeks. Spirometry showed normal FVC, FEV1,
and FEV1/FVC % with an obstruction of the small 
airways. Skin prick tests were positive to birch, 
mixed grass, mugwort, and Dermatophagoides 
pteronyssinus. Histamine challenge was also 
positive (PC20 = 4 mg mL-1), confirming asthma 
diagnosis.  Consequently, we performed serial PEFR 
measurement and bronchoprovocation testing.
Mean diurnal PEFR variations did not show 
significant difference between days at work and away 
from work (Figure 2).
Bronchoprovocation testing on days away from 
work and days at work showed a difference in PC20 
which did not reach two double concentrations of 
histamine (4 mg mL-1 vs. 2 mg mL-1).
As PEFR and NSBH changes did not significantly 
differ between days at work and days away from work, 
our diagnosis was WEA. Its management included 
pharmacological anti-asthma treatment and we 
recommended that the subject should avoid the 
current workplace if the disease could not be controlled 
by optimised therapy and improved working conditions 
after the installation of the new ventilation system.
DISCUSSION
Due to its growing prevalence over the last few 
decades, WRA has been recognized by public health 
authorities as a priority issue in many countries 
worldwide. As WRA claims rate in Washington 
State increased over 55 % in the period 1991-1999, 
Washington added WRA as a disease physicians must 
report to the state health officials. High-risk industries 
for WRA in Washington State include sawmills, plastic 
products manufacture, and car repair (3). 
Currently, isocyanate-containing coatings are found 
on almost every vehicle. Results from a Yale study (22) 
showed a 20 % prevalence of respiratory symptoms in 
automobile painters using isocyanate-based aerosol 
paints, but the production and use of these paints 
continues to grow (9). These chemicals are also 
considered an important cause of allergic occupational 
asthma in many countries throughout the world (e. g. 
US, Canada, and South Korea) (3, 11, 23).
Because of the many controversies, WRA 
diagnosis should not be made lightly. It is important 
Figure 2 Plot of maximum, mean, and minimum peak expiratory flow rate (PEFR) against time showing non-significant changes in mean PEFR 
diurnal variations on days away from work and days at work (16.6 % vs. 18.5 %, P = 0.423; independent samples t-test). Days away
from work 1-15, days at work 16-30.
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to distinguish different types of WRA, since their 
prevention and treatment may differ significantly (1). 
Underdiagnosing and overdiagnosing OA can both 
create a substantial burden for patients, their families, 
employers, health-care insurance providers, and the 
society as a whole (24).
Automobile spray painters using isocyanate-
containing aerosol paints in our study were employed 
in two autobody repair shops different in the size of 
business and premises. In fact, every autobody repair 
shop is an unique environment (9) that differs from 
others in work practices, workload, and the level of 
coating, and no two shops are the same. Literature 
describes different types of WRA in subjects employed 
in car repair industry. OA induced by isocyanates has 
become the model of allergic OA caused by low-
molecular-weight compounds (25, 26). According to 
Mapp et al. (26), the estimated prevalence of WRA 
among painters using isocyanate-based aerosol paints 
was 7.1 %. Toluene diisocyanae (TDI), methylene 
diphenyldiisocyanate (MDI), and hexamethilene 
diisocyanate (HDI) are known causative agents of 
allergic OA (27). Although the isocyanate-induced 
effects are widely cited, their pathways, as well as the 
importance of intensity, duration, and frequency of 
exposure are still not well understood (9, 20).
As neither of our subjects had elements for the 
diagnosis of RADS, our work-up included confirmation 
or exclusion of allergic OA. The gold standard for 
diagnosing allergic OA is the specific inhalation 
challenge (SIC), but it is not frequently used. It 
is expensive and time-consuming, and carries a 
significant health risk to the person being tested. 
Finally, the challenge may not provide the correct 
exposure and may produce false negative and false 
positive results. When performed in a laboratory, the 
challenge is controlled, but also artificial (24, 28). 
Commonly performed in routine practice are the 
“stop-resume” work tests using serial measurements 
of PEFR, NSBH and/or sputum eosinophilia (26, 
29). As Chiry et al. (29) reported that in some cases 
serial PEFR measurement failed to distinguish allergic 
OA from WEA, and indicated a need of additional 
tests, such as changes in airway responsiveness and 
immunologic tests, we reassessed the work-relatedness 
of asthma in our cases by serial bronchoprovocation 
testing. Similar to our previous study (30), in both 
cases the results of the two methods repeated each 
other, confirming the conclusion of Côté et al. (31) 
that the combination of serial PEFR measurement with 
serial measurement of NSBH does not add anything 
in differentiation between allergic OA and WEA to 
monitoring by PEFR alone.
We were unable to perform isocyanate challenge, 
so we did not confirm isocyanate as a causative agent 
of allergic OA in Subject 1. Even though isocyanates 
are the probable cause of allergic sensitisation and 
OA, other agents used by this subject (e.g. organic 
solvents) are not to be excluded. Allergy testing 
has a limited role in the diagnosis of isocyanate-
induced asthma, as it is caused by non IgE-mediated 
mechanisms. In a study including 43 TDI-induced OA 
patients of whom 81 % were spray painters, Park & 
Nahm (23) found specific IgE-antibody to isocyanate 
conjugates in 40 %, with no relation between its 
presence and any clinical parameter. On the other 
hand, it is well known that positive allergy tests to 
workplace allergens can not confirm the diagnosis 
of allergic OA, as they identify sensitisation, and not 
the disease itself (32). Subject 1 was a never-smoker 
and his SPTs to common inhalant allergens were 
negative. Several studies have suggested that atopy 
and smoking may be associated with development of 
allergic OA caused by isocyanates (33, 34). In contrast, 
other studies indicated that atopy and smoking did not 
contribute to specific sensitisation and development 
of isocyanate-induced asthma (35).
We can speculate whether WEA diagnosed in 
Subject 2 is reactivation of an undiagnosed pre-
existing childhood asthma with a long symptom-free 
period, triggered by current workplace exposure. It 
remains controversial whether the worsening of pre-
existing asthma induced by a high-level inhalation of 
irritants should be categorised as an “acute irritant-
induced asthma” or as WEA (36). Several investigators 
have proposed to extend the spectrum of irritant-
induced asthma to include new-onset asthma and 
reactivation of quiescent asthma in subjects repeatedly 
exposed to “moderate” or “excessive”, although 
poorly documented, concentrations of irritants at 
the workplace (37, 38). The evidence supporting this 
concept of “not-so-sudden RADS” is still very weak. 
We agree with the proposition of Vandenplas & Malo 
(1) that the delayed-onset asthma following repeated 
exposure to moderate or excessive concentrations 
of irritants can not be considered OA because the 
causal relationship between workplace exposure and 
the development of asthma can not be ascertained 
with a sufficient level of confidence.
The reader should note that our study has some 
limitations. We were unable to perform environmental 
measurements at the workplaces of the affected 
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subjects, so we could not document the effect of the 
level of exposure on WRA. Testing with workplace 
allergens could better present allergic sensitisation 
and its implications for the respiratory impairment in 
the affected subjects. As we did not perform SIC, we 
could not establish a relationship between its results 
and the data obtained from the serial PEFR and 
bronchoprovocation testing.
In conclusion, our findings confirm that spray 
painting is an occupation which involves the risk of 
respiratory impairment and WRA. They also confirm 
the need of regular medical examinations and 
implementation of appropriate measures to prevent 
adverse respiratory effects of workplace exposure in 
automobile spray painters.
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Sa`etak
PROFESIONALNA ASTMA U AUTOLAKIRERA: OPIS DVAJU SLU^AJEVA
U radu su opisana dva bolesnika koji su nakon rada s aerosolskom bojom na bazi izocijanata u autolakirerskoj 
radionici dobili astmu. U oba je slu~aja dijagnoza potvr|ena standardnim postupkom. Jedan je bolesnik bio 
atopi~an. Jedan je biv{i pu{a~, a drugi nikad nije pu{io. U obiteljskoj anamnezi nije bilo astme ni u jednog 
bolesnika. Simptomi su se javili nakon profesionalne izlo`enosti u trajanju od dvije odnosno tri godine. 
Budu}i da su oba bolesnika povezivala simptome s poslom, podvrgnuti su mjerenju vr{nog ekspiratornog 
protoka (engl. peak expiratory flow rate, krat. PEFR) te nizu bronhoprovokacijskih testova. U jednoga 
su bolesnika zamije}ene zna~ajne profesionalne dnevne promjene u PEFR-u i nespecifi~ne bronhalne 
hiperreaktivnosti, {to upu}uje na profesionalnu alergijsku astmu, dok je u drugoga ispitanika dijagnosticirano 
pogor{anje astme povezano s profesionalnom izlo`enosti. Na{i podaci potvr|uju pretpostavku da posao 
autolakiranja sprejem nosi pove}ani rizik od respiratornih tegoba i astme.
KLJU^NE RIJE^I: bronhoprovokacijski test, izocijanati, respiratorne tegobe, vr{ni ekspiratorni 
protok
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